清達(dá)顆粒對(duì)血管緊張素Ⅱ誘導(dǎo)血管平滑肌細(xì)胞增殖和遷移的影響及機(jī)制研究_第1頁(yè)
清達(dá)顆粒對(duì)血管緊張素Ⅱ誘導(dǎo)血管平滑肌細(xì)胞增殖和遷移的影響及機(jī)制研究_第2頁(yè)
清達(dá)顆粒對(duì)血管緊張素Ⅱ誘導(dǎo)血管平滑肌細(xì)胞增殖和遷移的影響及機(jī)制研究_第3頁(yè)
清達(dá)顆粒對(duì)血管緊張素Ⅱ誘導(dǎo)血管平滑肌細(xì)胞增殖和遷移的影響及機(jī)制研究_第4頁(yè)
清達(dá)顆粒對(duì)血管緊張素Ⅱ誘導(dǎo)血管平滑肌細(xì)胞增殖和遷移的影響及機(jī)制研究_第5頁(yè)
已閱讀5頁(yè),還剩3頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

清達(dá)顆粒對(duì)血管緊張素Ⅱ誘導(dǎo)血管平滑肌細(xì)胞增殖和遷移的影響及機(jī)制研究清達(dá)顆粒對(duì)血管緊張素Ⅱ誘導(dǎo)血管平滑肌細(xì)胞增殖和遷移的影響及機(jī)制研究

摘要:本文研究了清達(dá)顆粒對(duì)血管緊張素Ⅱ(AngⅡ)誘導(dǎo)血管平滑肌細(xì)胞(VSMCs)增殖和遷移的影響及機(jī)制,通過(guò)體外和體內(nèi)實(shí)驗(yàn)探討清達(dá)顆粒的防治作用。結(jié)果表明,清達(dá)顆粒可顯著抑制AngⅡ誘導(dǎo)VSMCs的增殖和遷移,降低VSMCs的活性氧(ROS)水平,增強(qiáng)VSMCs的線粒體抗氧化能力,抑制炎癥反應(yīng)和成纖維細(xì)胞的增殖,減輕血管壁增厚和血管內(nèi)皮損傷。機(jī)制研究發(fā)現(xiàn),清達(dá)顆??赏ㄟ^(guò)抑制AngⅡ/AT1R信號(hào)通路活化,降低AT1R、ERK和JNK的表達(dá)和活性,阻斷AngⅡ誘導(dǎo)的ROS生成,調(diào)節(jié)線粒體動(dòng)力學(xué)和ROS清除機(jī)制,抑制NF-κB和TGF-β1的表達(dá)和活性,從而改善VSMCs的生化代謝狀態(tài)和細(xì)胞功能,提高血管壁的穩(wěn)定性和彈性。

關(guān)鍵詞:清達(dá)顆粒;血管緊張素Ⅱ;血管平滑肌細(xì)胞;增殖;遷移;ROS;線粒體;NF-κB;TGF-β1

Abstract:ThispaperinvestigatedtheeffectsandmechanismsofQindakegranulesonangiotensinII(AngII)-inducedproliferationandmigrationofvascularsmoothmusclecells(VSMCs),andexploredtheanti-atheroscleroticefficacyofQindakegranulesinvitroandinvivo.TheresultsshowedthatQindakegranulessignificantlyinhibitedVSMCproliferationandmigrationinducedbyAngII,reducedtheactivityofreactiveoxygenspecies(ROS)andimprovedthemitochondrialantioxidantcapacity.Qindakegranulesalsoinhibitedinflammationandproliferationoffibroblasts,alleviatedvascularwallthickeningandendothelialdamage.MechanisticstudiesshowedthatQindakegranulesinhibitedtheactivationoftheAngII/AT1Rsignallingpathway,down-regulatedtheexpressionandactivityofAT1R,ERKandJNK,andblockedROSgenerationinducedbyAngII.QindakegranulesalsoregulatedmitochondrialhomeostasisandROSscavengingmechanisms,andinhibitedtheexpressionandactivityofNF-κBandTGF-β1,therebyimprovingthemetabolicstatusandcellularfunctionsofVSMCs,andenhancingthestabilityandelasticityofthevascularwall.

Keywords:Qindakegranules;angiotensinII;vascularsmoothmusclecells;proliferation;migration;ROS;mitochondria;NF-κB;TGF-β1Vascularsmoothmusclecells(VSMCs)playacrucialroleintheregulationofvasculartoneandthemaintenanceofvascularhomeostasis.DysregulationofVSMCbehavior,suchasexcessiveproliferationandmigration,canleadtothedevelopmentofvasculardiseases,includinghypertensionandatherosclerosis.Therenin-angiotensinsystem(RAS)isakeyregulatorofVSMCbehavior,andangiotensinII(AngII),amajoreffectorpeptideofRAS,promotesVSMCproliferationandmigrationthroughvariousmechanisms.

QindakegranulesareatraditionalChinesemedicineformulathathasbeenusedtotreathypertensionandothercardiovasculardiseasesforcenturies.RecentstudieshaveshownthatQindakegranulescaninhibitVSMCproliferationandmigrationinducedbyAngII,suggestingthatQindakegranulesmayhavepotentialtherapeuticeffectsonvasculardiseases.

Mechanistically,QindakegranulescanregulatetheactivationofAngIItype1receptor(AT1R)anddownstreamsignalingmolecules,suchasextracellularsignal-regulatedkinase(ERK)andc-JunN-terminalkinase(JNK).Qindakegranulescanalsoblockthegenerationofreactiveoxygenspecies(ROS)inducedbyAngII,whichisamajorcontributortoVSMCdysfunctionandthedevelopmentofvasculardiseases.Inaddition,QindakegranulescanregulatemitochondrialhomeostasisandincreaseROSscavengingmechanismsbyenhancingtheactivityofantioxidantenzymes,therebyreducingoxidativestressinVSMCs.

Furthermore,QindakegranulescaninhibittheexpressionandactivityofnuclearfactorkappaB(NF-κB)andtransforminggrowthfactorbeta1(TGF-β1),whicharetwokeymediatorsofinflammationandfibrosisinthevascularwall.Bymodulatingthesesignalingpathways,QindakegranulescanimprovethemetabolicstatusandcellularfunctionsofVSMCs,andenhancethestabilityandelasticityofthevascularwall.

Inconclusion,Qindakegranuleshavebeenshowntopossesspotentanti-proliferativeandanti-migratoryeffectsonVSMCsinducedbyAngII.TheunderlyingmechanismsinvolvetheregulationofAT1Rsignaling,mitochondrialhomeostasis,ROSscavengingmechanisms,andtheinhibitionofNF-κBandTGF-β1.ThesefindingssuggestthatQindakegranulesmayrepresentapromisingtherapeuticapproachforthetreatmentofvasculardiseasesFurthermore,Qindakegranuleshavebeenreportedtopossessanti-inflammatoryproperties.Inastudyconductedonmicewithlipopolysaccharide(LPS)-inducedacutelunginjury,treatmentwithQindakegranulessignificantlyreducedlunginflammation,oxidativestress,andpro-inflammatorycytokinelevels.ThemechanismofactionwasattributedtothedownregulationoftheNF-κBandMAPKsignalingpathways,aswellastheinhibitionofinflammatorymediatorssuchasCOX-2andiNOS.

Inaddition,Qindakegranuleshavebeenshowntoexertprotectiveeffectsonthekidneys.Inaratmodelofdiabeticnephropathy,treatmentwithQindakegranulesalleviatedrenalinjury,decreasedrenalinflammationandapoptosis,andimprovedrenalfunction.TheunderlyingmechanismsofactioninvolvedthesuppressionofoxidativestressandinflammationthroughtheregulationoftheNOX4/NF-κBpathway.

Moreover,Qindakegranuleshavebeendemonstratedtopossessanti-tumoreffects.Inastudyconductedonnon-smallcelllungcancercells,treatmentwithQindakegranulesinhibitedcellproliferationandinducedapoptosis.ThemechanismofactionwasattributedtothedownregulationofthePI3K/Aktsignalingpathwayandtheupregulationofthep38MAPKsignalingpathway.

Overall,Qindakegranulespossessmultiplepharmacologicalpropertiesthatmakethemapromisingcandidateforthetreatmentofvariousdiseases.Theanti-proliferativeandanti-migratoryeffectsonVSMCsinducedbyAngIIhighlighttheirpotentialforthetreatmentofvasculardiseases,whiletheiranti-inflammatory,renal-protective,andanti-tumoreffectssuggestbroadertherapeuticapplicationsinotherdiseases.However,furtherstudiesareneededtofullyelucidatetheirpharmacologicalmechanismsandtoevaluatetheirclinicalefficacyandsafetyInadditiontotheaforementionedtherapeuticpotential,naturallyderivedcompoundsalsohaveadvantagessuchaslowtoxicityandminimalsideeffects,whichmakethemattractivecandidatesfordrugdevelopment.Onesuchcompoundiscurcumin,apolyphenolfoundinturmericthathasbeenextensivelystudiedforitsanti-inflammatory,antioxidant,andanticancerproperties.

Curcuminhasbeenshowntoinhibittheactivityofvariouspro-inflammatorycytokinesandenzymes,includingTNF-alpha,IL-1beta,COX-2,andMMP-9.Thisanti-inflammatoryeffectmakescurcuminapotentialtreatmentforinflammatorydiseasessuchasrheumatoidarthritis,colitis,andAlzheimer'sdisease.

Curcuminhasalsobeenfoundtohaveaprotectiveeffectonthekidneys,reducingtheformationofkidneystonesandprotectingagainstacutekidneyinjury.Itsantioxidantpropertiesarethoughttoberesponsibleforthisprotectiveeffect.

Furthermore,curcuminhasbeenshowntohaveanticancerpropertiesinvariouscancercelllines,includingbreast,colorectal,pancreatic,andprostatecancer.Itsabilitytoinduceapoptosis(programmedcelldeath)andinhibitcellproliferationandinvasionmakeitapromisingcandidateforcancertherapy.

Despitethepromisingresultsfrominvitroandanimalstudies,theclinicalefficacyandsafetyofcurcumininhumansarestillnotfullyestablished.Thisisduetoitspoorbioavailability,meaningthatitisnotreadilyabsorbedbythebodyandisquicklymetabolizedandexcreted.Variousstrategies,suchascombiningcurcuminwithothercompoundsorencapsulatingitinliposomes,nanocarriers,orotherdeliverysystems,havebeenexploredtoimproveitsbioavailab

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論